SEC Company Response from Beam Therapeutics Inc. (BEAM) (CIK 0001745999) (BEAM) — Feb 3, 2020
Beam Therapeutics Inc. (BEAM) (CIK 0001745999)
Date: Feb. 3, 2020 · CIK: 0001745999 · Accession: 0001193125-20-022637
AI Filing Summary & Sentiment
File numbers found in text: 333-233985
Letter
Underwriter Acceleration Request
J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
Jefferies LLC
520 Madison Avenue
New York, New York 10022
Barclays Capital Inc.
745 Seventh Avenue
New York, New York 10019
February 3, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C.
Re: Beam Therapeutics Inc.
Registration Statement on Form S-1 (File No. 333-233985)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Beam Therapeutics Inc. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 PM, Eastern Time, on February 5, 2020, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Ropes & Gray LLP, request by telephone that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that approximately 1,880 copies of the Preliminary Prospectus included in the above-named Registration Statement, as amended, were distributed during the period from January 27, 2020 through the date hereof, to prospective underwriters, institutions, dealers and others.
We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Acting severally on behalf of themselves and the
Show Raw Text
CORRESP 1 filename1.htm Underwriter Acceleration Request J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Jefferies LLC 520 Madison Avenue New York, New York 10022 Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 February 3, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Beam Therapeutics Inc. Registration Statement on Form S-1 (File No. 333-233985) Request for Acceleration of Effective Date Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Beam Therapeutics Inc. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 PM, Eastern Time, on February 5, 2020, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Ropes & Gray LLP, request by telephone that such Registration Statement be declared effective. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that approximately 1,880 copies of the Preliminary Prospectus included in the above-named Registration Statement, as amended, were distributed during the period from January 27, 2020 through the date hereof, to prospective underwriters, institutions, dealers and others. We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, Acting severally on behalf of themselves and the several underwriters J.P. MORGAN SECURITIES LLC By: /s/ David Ke Name: David Ke Title: Executive Director JEFFERIES LLC By: /s/ Dustin Tyner Name: Dustin Tyner Title: Managing Director BARCLAYS CAPITAL INC. By: /s/ Victoria Hale Name: Victoria Hale Title: Vice President [Signature Page to Underwriters’ Acceleration Request]